A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Condition: B-cell Non Hodgkin Lymphoma Interventions: Drug: Odronextamab; Drug: Loncastuximab tesirine; Drug: Rituximab; Drug: Ifosfamide; Drug: Carboplatin; Drug: Etoposide; Drug: Etoposide Phosphate; Drug: Dexamethasone; Biological: CAR T-cells (TBC) Sponsors: University of Birmingham; Cancer Research UK; Fight Kids Cancer; Regeneron Pharmaceuticals; ADC Therapeutics SA Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
A Phase 2 Clinical Trial to Evaluate Zanubrutinib Combined With BR (Bendamustine/Rituximab) Regimen in Subjects With Newly-diagnosed Waldenstr öm's Macroglobulinemia
Condition: Waldenström's Macroglobulinemia Intervention: Drug: zanubrutinib,bendamustine,rituximab Sponsors: Shanghai Changzheng Hospital; RenJi Hospital; Huashan Hospital; Shanghai 6th People's Hospital; Huadong Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2023 Category: Research Source Type: clinical trials
